Funding · Agriculture & Food Systems

StrainX Bioworks raises ₹124 Cr from Prime Venture, Leo Capital

What they do

StrainX Bioworks uses synthetic biology and precision fermentation to make alternative proteins

The startup raised around ₹124 Cr ($13 Mn) in a round led by Prime Venture Partners and Leo Capital

Funds will expand its Bhopal bio-manufacturing unit and start commercial-scale production

StrainX Bioworks came out of stealth mode.
It raised around ₹124 Cr ($13 Mn) in a funding round.
The round was led by Prime Venture Partners and Leo Capital.
The company will use the funds for capacity expansion at its Bhopal bio-manufacturing unit.
It plans to commence commercial-scale production.
The company will also ramp up hiring.
It aims to double headcount to 200 by FY27-end.
It will also expand into new science verticals.

StrainX Bioworks uses synthetic biology (engineering organisms to produce useful substances) and precision fermentation (using microbes to make specific proteins) for alternative proteins.
It serves the food, nutrition, materials, and cosmetics sectors.
Its Bhopal facility has a 10,000 litre capacity.
The company plans to commence commercial-scale production.
It aims to double headcount to 200 by FY27-end.

Product: Alternative proteins and bio-based ingredients developed through synthetic biology and precision fermentation
Customers: Food, nutrition, healthcare, agriculture, cosmetics, and materials industries
How it makes money: Biotech manufacturing using precision fermentation with 10,000-litre fermentation facility
What sets it apart: 100-person team including IIT Delhi alumni with proprietary strain engineering and fermentation capabilities